Following treatment, CSF CXCL13 decreased in neuroborreliosis (e.g., 3.2-fold in a study by Moniuszko et al. [43]), but the concentration was still higher in comparison to the control group, where it was undetectable. Here, CXCL13 is linked to Lyme disease.